From: The association between serum testosterone levels and metabolic syndrome among women
Overall population | ||||
---|---|---|---|---|
Serum testosterone level (ng/mL) | Unadjusted | Adjusteda | ||
OR [95CI]b | Pc | OR [95CI] | P | |
Metabolic syndrome | ||||
Q1 (< 12.99) | Ref | Ref | ||
Q2 (12.99–19.38) | 0.641 [0.493–0.835] | 0.01 | 0.687 [0.511–0.924] | 0.05 |
Q3 (19.39–28.38) | 0.476 [0.362–0.626] | 0.001 | 0.575 [0.421–0.784] | 0.001 |
Q4 (≥ 28.40) | 0.390 [0.294–0.517] | 0.001 | 0.536 [0.386–0.745] | 0.001 |
Elevated waist circumference (> 88 cm) | ||||
Q1 (< 12.99) | Ref | Ref | ||
Q2 (12.99–19.38) | 0.766 [0.582–1.008] | 0.923 [0.585–1.456] | ||
Q3 (19.39–28.38) | 0.699 [0.532–0.918] | 0.05 | 0.898 [0.553–1.459] | |
Q4 (≥ 28.40) | 0.647 [0.493–0.848] | 0.01 | 1.005 [0.611–1.651] | |
Elevated serum triglycerides (≥ 150 mg/dL) | ||||
Q1 (< 12.99) | Ref | Ref | ||
Q2 (12.99–19.38) | 0.648 [0.500-0.841] | 0.001 | 0.651 [0.493–0.860] | 0.01 |
Q3 (19.39–28.38) | 0.472 [0.361–0.619] | 0.001 | 0.541 [0.404–0.725] | 0.001 |
Q4 (≥ 28.40) | 0.372 [0.281–0.492] | 0.001 | 0.488 [0.357–0.666] | 0.001 |
Reduced HDL-C (< 50 mg/dL) | ||||
Q1 (< 12.99) | Ref | Ref | ||
Q2 (12.99–19.38) | 0.805 [0.620–1.044] | 0.717 [0.543–0.948] | 0.05 | |
Q3 (19.39–28.38) | 0.769 [0.592–0.999] | 0.05 | 0.618 [0.464–0.824] | 0.01 |
Q4 (≥ 28.40) | 0.671 [0.515–0.875] | 0.01 | 0.520 [0.384–0.703] | 0.001 |
Elevated blood pressure (≥ 130/85 mm Hg) | ||||
Q1 (< 12.99) | Ref | Ref | ||
Q2 (12.99–19.38) | 0.646 [0.498–0.836] | 0.01 | 0.932 [0.699–1.243] | |
Q3 (19.39–28.38) | 0.468 [0.358–0.612] | 0.001 | 0.854 [0.630–1.159] | |
Q4 (≥ 28.40) | 0.392 [0.298–0.516] | 0.001 | 0.814 [0.588–1.127] | |
Elevated serum glucose level (≥ 110 mg/dL) | ||||
Q1 (< 12.99) | Ref | Ref | ||
Q2 (12.99–19.38) | 0.675 [0.500-0.912] | 0.05 | 0.771 [0.561–1.060] | |
Q3 (19.39–28.38) | 0.564 [0.413–0.770] | 0.001 | 0.744 [0.532–1.039] | |
Q4 (≥ 28.40) | 0.354 [0.251-0.500] | 0.001 | 0.525 [0.361–0.763] | 0.001 |